People · Operator
Named in public records as an officer, director or promoter · active 2009–2018 · Other, Healthtech, Biotechnology
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Kyruus, Inc. | — | Other | Series C | $196.2M | $388.0M | 2012 |
| Cala Health, Inc. | — | Healthtech | Series C | $166.1M | $369.8M | 2016 |
| KALA BIO, Inc. | — | Biotechnology | Series C | $158.8M | $8.3M | 2009 |
| Genocea Biosciences, Inc. | — | Biotechnology | Series C | $153.6M | $3.0B | 2010 |
ROBERT PAULL at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside ROBERT PAULL on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Kevin Bitterman | 2 | 15 |
| Robert Langer | 1 | 36 |
| Bryan Roberts | 1 | 18 |
| Asish Xavier | 1 | 18 |
| Ali Behbahani | 1 | 17 |
| LEON CHEN | 1 | 15 |
| William Clark | 1 | 12 |
| Michael Higgins | 1 | 9 |
| Vijay Lathi | 1 | 8 |
| Simeon George | 1 | 8 |
| Dan Nova | 1 | 8 |
| Stephen Hoffman | 1 | 7 |
| Michael Carusi | 1 | 7 |
| Robert Higgins | 1 | 7 |
| Robert Tepper | 1 | 7 |
| John Kuelper | 1 | 6 |
| Michael A. Carusi | 1 | 6 |
| Robert Coppedge | 1 | 6 |
| Renee Ryan | 1 | 6 |
| JULIE YOO | 1 | 5 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.